EP Patent
EP0100052A1 — PGE type compositions encapsulated by acid isolated gelatin
Assigned to Syntex USA LLC · Expires 1984-02-08 · 42y expired
What this patent protects
Soft-shelled gelatin capsule formulations of PGE-type compounds having superior stability are prepared by using acid isolated gelatin.
USPTO Abstract
Soft-shelled gelatin capsule formulations of PGE-type compounds having superior stability are prepared by using acid isolated gelatin.
Drugs covered by this patent
- Epanova (OMEGA-3-CARBOXYLIC ACIDS) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.